Ketoconazole AID-SCFM: Withdrawal of the marketing authorisation application



On 23 February 2015, Agenzia Industrie Difesa - Stabilimento Chimico Farmaceutico Militare officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Ketoconazole AID-SCFM, for the treatment of Cushing's syndrome.

  • List item

    Questions and answers on the withdrawal of the marketing authorisation application for Ketoconazole AID-SCFM (ketoconazole) (PDF/73.16 KB)

    First published: 27/03/2015
    Last updated: 27/03/2015

  • Key facts

    Ketoconazole AID-SCFM
    Product number
    International non-proprietary name (INN) or common name
    • ketoconazole
    Active substance
    • Ketoconazole
    Date of withdrawal
    Company making the application
    Agenzia Industrie Difesa-Stabilimento Chimico Farmaceutico Militare
    Withdrawal type
    Initial authorisation

    All documents

    Related information on withdrawals

    A question-and-answer (Q&A) document provides a summary of the CHMP's evaluation of the medicine at the time of the withdrawal of the application, and includes a link to the company's formal withdrawal letter.

    An assessment report is published when the application is withdrawn after the first stage of the CHMP's evaluation is completed ('day 120').

    How useful was this page?

    Add your rating
    1 rating